BIOTON S.A.’s Post

Exciting breakthrough in diabetes research! A recent study, published on November 1, 2023, reveals that inhibiting polyamine biosynthesis can help preserve β cell function in type 1 diabetes. This open-access research sheds light on a potential avenue for enhancing treatment strategies. Explore the details and implications of this discovery in the quest for improved diabetes management. 🧪🔬 #Type1Diabetes #MedicalResearch #DiabetesTreatment #ScientificBreakthrough 🌐📚 Inhibition of polyamine biosynthesis preserves β cell function in type 1 diabetes Open AccessPublished:November 01, 2023DOI:https://lnkd.in/ewgY95eA

FibroBiologics is exploring a new fibroblast-based approach to diabetes treatment, focusing on pancreatic beta cell spheroids for insulin secretion. This development could offer alternative management strategies for insulin-dependent diabetes. For a deeper understanding of this approach, hear from our Chief Scientific Officer, Dr. Hamid Khoja, about the implications for managing insulin-dependent diabetes. For more, please visit: https://bit.ly/3TmsS6j #DiabetesResearch #BiotechInnovation #Healthcare

Looking forward to engaging with thought leaders across academia, industry and healthcare on the future of a more personalised, tolerable approach to GLP-1 therapy at the American Diabetes Association annual conference later this month. GLP-1s have brought a step change in outcomes for patients living with T2D and obesity but with 30% of patients stopping after 4 weeks before reaching target dose, we need a more personalised therapy regimen (https://lnkd.in/e_H--miH). At Closed Loop Medicine we are taking a precision medicine approach to disease management - including GLP-1. Treating the individual, not just the disease. #ADA2024 #TechBio #PrecisionCare #GLP1

November 8 is CTEPH Awareness Day. "CTEPH" stands for Chronic Thromboembolic Pulmonary Hypertension, a rare form of pulmonary hypertension. Check out the information materials about CTEPH available on the Pulmonary Hypertension Knowledge Sharing Platform , which include booklets, videos, patient testimonials, scientific articles, clinical guidelines, reports of conferences and other useful resources. These materials are available in several languages and the entire website can be translated into 20 languages. #pulmonaryhypertension #pulmonaryarterialhypertension #PAH #chronicthromboembolicpulmonaryhypertension #CTEPH #knowledgesharing #knowledgeexchange #patientempowerment #patienteducation #allianceforph #organtransplant #organdonation #transplant #lungtransplant HTaPFrance Stichting Pulmonale Hypertensie / PH Association the Netherlands PH Belgium - Pulmonale Hypertensie vzw AIPI Italian Pulmonary Hypertension Association Pulmoner Hipertansiyon ve Skleroderma Hasta Dernegi Hellenic Community for Pulmonary Hypertension Pulmonale Hypertonie E.V. Ieva Plume  https://lnkd.in/d8eRrVXy

The American Diabetes Association returns for its 84th Annual Scientific Session on June 21st, bringing together researchers, healthcare professionals, and industry experts to delve into the latest advancements in diabetes research, treatment, and care.    With session themes focusing on therapeutics, management of acute or chronic complications, and behavioural medicine, it’s worth highlighting that the effectiveness of any treatment depends on its efficacy, safety, and patient adherence. Patient-centric integrated care approaches that enable real-time patient monitoring play a pivotal role in ensuring medication adherence and mitigating the risk and severity of complications associated with obesity, such as diabetes and hypertension.   Get in touch to arrange a meeting with Hakim Yadi Ph.D. OBE! Learn more about how Closed Loop Medicine is facilitating personalized disease management through our expanding portfolio of drug-plus-software combination products, to improve the effectiveness of medicines, such as GLP-1s, while reducing the impact of adverse effects:  https://shorturl.at/fMcea �� #ADA2024 #TechBio #PrecisionCare

I'm pleased to share an exciting development in the treatment of arterial hypertension. Prof. Dagmara Hering from Klinika Nadciśnienia Tętniczego i Diabetologii GUMed has been a key contributor to a groundbreaking study in the United States focusing on an innovative method of arterial hypertension treatment. The study revolves around the percutaneous renal denervation, a minimally invasive treatment that aims to provide immediate blood pressure reduction during the procedure. This method shows promise in treating arterial hypertension, a chronic condition that can lead to severe health issues if left unmanaged. To read more about this innovative approach to treating arterial hypertension and its potential to revolutionize healthcare, click on the following link: https://ift.tt/ojpODmN The in-depth article covers the significance of arterial hypertension, the potential of percutaneous renal denervation, and the VERVE Medical system developed by the team at the Arizona State University. Stay informed about this cutting-edge advancement and its impact on healthcare by accessing the full article.

I recently spoke with American Diabetes Association (ADA) news to highlight an upcoming symposium happening at the #ADA2024 Scientific Sessions, June 2024 Orlando, Florida. Our symposium being held Monday, June 24 at 1:30 – 3:00 PM EST will discuss how diabetes technology is changing diabetes care in the real world. I will be presenting how connected insulin pens and caps are facilitating precision insulin management for individuals choosing to deliver their insulin with injections. Data from smart insulin pens and caps are shining the spotlight on injection therapy and revealing gaps and opportunities to improve care for this population.  #realworlddata, #technology, #education, #insulin #precision #data #diabetes #type1diabetes #type2diabetes #t1d #t2d #symposium #Orlando

Insulet was proud to present OP5-003 Trial results at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in Florence, Italy. Professor Eric Renard, MD, PhD of Montpellier University Hospital, shared evidence of the efficacy and safety of the automated Omnipod 5 System compared to insulin pump therapy with continuous glucose monitoring (CGM) in adults with type 1 diabetes (T1D) in the United States and France. Omnipod 5 use led to a 17.5% improvement in time in range (TIR), decreased HbA1c, decreased percentage of time in hypoglycemia, and decreased mean glucose in individuals with baseline HbA1c levels above the recommended target. #ATTD24

Revolutionizing Diabetes Care: New Insights into Old Diabetes Drug Exciting News in Diabetes Research! Researchers at the University of California San Diego School of Medicine have uncovered new insights into an old diabetes drug, Thiazolidinediones (TZDs), once sidelined due to side effects. They've discovered how TZDs work at a molecular level, potentially leading to new, safer treatments for type 2 diabetes. Check out the link for more details on this topic: [link](https://lnkd.in/dQDNWCRU). Join our Diabetes Champions community for updates on this groundbreaking research and more engaging content! #DiabetesResearch #HealthcareInnovation #MedicalResearch #Type2Diabetes #UCSanDiegoMedicine

New guidelines from the American Association of Clinical Chemistry (AACC) and American Diabetes Association (ADA) address laboratory measures in the diagnosis and management of diabetes. The document, entitled, "Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus," is primarily aimed at both laboratory professionals and clinicians involved in diabetes care. The guidance is focused "on the practical aspects of care in order to assist with decisions regarding the use or interpretation of laboratory tests while screening, diagnosing, or monitoring patients with diabetes," write David B. Sacks, MBChB, chief of the clinical chemistry service at the National Institutes of Health (NIH), Bethesda, Maryland, and co-authors. It was published online July 20 in both Clinical Chemistry and Diabetes Care, including the guidelines and executive summary.  #diabetes #diabeteseducation #diabetesawareness #diabetesmanagement #diabetescare #ADA #AACC https://lnkd.in/ehJvTyxu